Animal Models to Study Emerging Technologies Against SARS-CoV-2

被引:0
|
作者
Jhinuk Basu Mullick
Chelsey S. Simmons
Janak Gaire
机构
[1] University of Florida,Department of Mechanical & Aerospace Engineering, Herbert Wertheim College of Engineering
[2] University of Florida,Division of Cardiovascular Medicine, J. Crayton Pruitt Family Department of Biomedical Engineering
来源
Cellular and Molecular Bioengineering | 2020年 / 13卷
关键词
COVID-19; ACE2 receptor; Vaccine studies; Pathogenesis; Diagnostics; Transgenic models; Non-human primates; Domestic pets; Farm animals;
D O I
暂无
中图分类号
学科分类号
摘要
New technologies are being developed toward the novel coronavirus SARS-CoV-2 to understand its pathogenesis and transmission, to develop therapeutics and vaccines, and to formulate preventive strategies. Animal models are indispensable to understand these processes and develop and test emerging technologies; however, the mechanism of infection for SARS-CoV-2 requires certain similarities to humans that do not exist in common laboratory rodents. Here, we review important elements of viral infection, transmission, and clinical presentation reflected by various animal models readily available or being developed and studied for SARS-CoV-2 to help bioengineers evaluate appropriate preclinical models for their emerging technologies. Importantly, applications of traditional mice and rat models are limited for studying SARS-CoV-2 and development of COVID-19. Non-human primates, Syrian hamsters, ferrets, cats, and engineered chimeras mimic the human infection more closely and hold strong potential as animal models of SARS-CoV-2 infection and progression of resulting human disease.
引用
收藏
页码:293 / 303
页数:10
相关论文
共 50 条
  • [31] A SARS-CoV-2: Companion Animal Transmission and Variants Classification
    Pandit, Rachana
    Matthews, Qiana L.
    PATHOGENS, 2023, 12 (06):
  • [32] Animal models for SARS-CoV-2 infection: A tool for vaccine and therapeutic research
    Faslu Rahman, C.K.
    Sharun, Khan
    Jose, Bosco
    Sivaprasad, M.S.
    Jisna, K.S.
    Trends in Biomaterials and Artificial Organs, 2020, 34 : 78 - 82
  • [33] Stability of Neutralizing Antibody of PastoCoAd Vaccine Candidates against a Variant of Concern of SARS-CoV-2 in Animal Models
    Panahi, Mohammad
    Teimoori, Aali
    Esmaeili, Saber
    Aminianfar, Hossein
    Milani, Alireza
    Hosseini, Seyed Younes
    Esmaeili, Parisa
    Biglari, Alireza
    Baesi, Kazem
    IRANIAN BIOMEDICAL JOURNAL, 2024, 28 (04) : 208 - 214
  • [34] Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Wei, Xiaohui
    Rong, Na
    Liu, Jiangning
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
    Khoury, David S.
    Wheatley, Adam K.
    Ramuta, Mitchell D.
    Reynaldi, Arnold
    Cromer, Deborah
    Subbarao, Kanta
    O'Connor, David H.
    Kent, Stephen J.
    Davenport, Miles P.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (12) : 727 - 738
  • [36] Ferrets are valuable models for SARS-CoV-2 research
    Ciurkiewicz, Malgorzata
    Armando, Federico
    Schreiner, Tom
    de Buhr, Nicole
    Pilchova, Veronika
    Krupp-Buzimikic, Vanessa
    Gabriel, Guelsah
    von Koeckritz-Blickwede, Maren
    Baumgaertner, Wolfgang
    Schulz, Claudia
    Gerhauser, Ingo
    VETERINARY PATHOLOGY, 2022, 59 (04) : 661 - 672
  • [37] Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern
    Iqbal, Reema
    Khan, Sadia
    Ali, Haroon Muhammad
    Khan, Maham
    Wahab, Shahid
    Khan, Tariq
    FRONTIERS IN NANOTECHNOLOGY, 2022, 4
  • [38] Mink, SARS-CoV-2, and the Human-Animal Interface
    Fenollar, Florence
    Mediannikov, Oleg
    Maurin, Max
    Devaux, Christian
    Colson, Philippe
    Levasseur, Anthony
    Fournier, Pierre-Edouard
    Raoult, Didier
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [39] Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
    Mueller, Katharina
    Girl, Philipp
    Giebl, Andreas
    von Buttlar, Heiner
    Dobler, Gerhard
    Bugert, Joachim J.
    Gruetzner, Stefanie
    Wolfel, Roman
    JOURNAL OF CLINICAL VIROLOGY, 2021, 142
  • [40] Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
    Banihashemi, Seyed Reza
    Es-haghi, Ali
    Mehrabadi, Mohammad Hossein Fallah
    Nofeli, Mojtaba
    Mokarram, Ali Rezaei
    Ranjbar, Alireza
    Salman, Mo
    Hajimoradi, Monireh
    Razaz, Seyad Hossein
    Taghdiri, Maryam
    Bagheri, Mohsen
    Dadar, Maryam
    Hassan, Zuhair Mohammad
    Eslampanah, Mohammad
    Najafabadi, Zahra Salehi
    Lotfi, Mohsen
    Khorasani, Akbar
    Rahmani, Fereidoon
    FRONTIERS IN IMMUNOLOGY, 2022, 13